Tilray | TRLY - Market Capitalization


Tilray reported $2.68B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 6M 1000K Jun/2026
Aurora Cannabis CAD 318.09M 145.93M Nov/2026
Avita Medical AUD 127.11M 21.64M Jun/2026
Canopy Growth CAD 88.38M 494.19M Nov/2026
Cronos Group USD 2B 781.98M Nov/2026
Dianthus Therapeutics USD 2.46B 2.87B Nov/2026
Divis Laboratories Ltd INR 3.07T 598.82B Nov/2026
Ionis Pharmaceuticals USD 4.52B 2.9B Nov/2026
IQVIA Holdings USD 48.06B 3.81B Nov/2026
Moderna USD 99.14B 22.26B Nov/2026
Organigram Holdings CAD 128.48M 74.94M Nov/2026
Organon & Co USD 3.55B 49.18M Nov/2026
Revvity USD 19.52B 2.61B Nov/2026
Tectonic Therapeutic USD 649M 69M Jun/2026
Viatris USD 22.53B 2.18B Nov/2026
Xeris Pharmaceuticals USD 1.44B 70M Nov/2026
Zealand Pharma A/S 20.84B 12.51B Mar/2026